Cargando…
A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial
BACKGROUND: About 5% of breast cancer cases are metastatic at diagnosis, and 20%-30% of localized breast cancer cases become secondarily metastatic. Patients frequently report many detrimental symptoms related to metastasis and treatments. The physical, biological, psychological, and clinical benefi...
Autores principales: | Delrieu, Lidia, Pérol, Olivia, Fervers, Béatrice, Friedenreich, Christine, Vallance, Jeff, Febvey-Combes, Olivia, Pérol, David, Canada, Brice, Roitmann, Eva, Dufresne, Armelle, Bachelot, Thomas, Heudel, Pierre-Etienne, Trédan, Olivier, Touillaud, Marina, Pialoux, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137283/ https://www.ncbi.nlm.nih.gov/pubmed/30166274 http://dx.doi.org/10.2196/10487 |
Ejemplares similares
-
Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study
por: Delrieu, Lidia, et al.
Publicado: (2020) -
Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial
por: Delrieu, Lidia, et al.
Publicado: (2021) -
Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer
por: Delrieu, Lidia, et al.
Publicado: (2021) -
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial
por: Delrieu, Lidia, et al.
Publicado: (2020) -
P02-16 Implementation of a program based on adapted physical activity and recommendations for second cancers prevention for adolescents and young adults with cancer: PREVAPAJA study
por: Mongondry, Rodolf, et al.
Publicado: (2022)